Table: Ono Pharm -9-MTH group results (IFRS)

ONO PHARMACEUTICAL

01/02/2021 03:00

Feb 1 (Reuters)- 
              Ono Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2020        Dec 31, 2019     Mar 31, 2021 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              234.93              225.30           309.00    
                   (+4.3 pct)          (+0.9 pct)       (+5.7 pct)  
  Operating           82.19               66.05            94.00    
                   (+24.4 pct)         (+26.7 pct)      (+21.3 pct) 
  Pretax              84.66               68.69            95.50    
                   (+23.3 pct)         (+24.4 pct)      (+19.8 pct) 
  Net                 66.49               51.83            74.00    
                   (+28.3 pct)         (+20.2 pct)      (+23.9 pct) 
  EPS Basic        133.20 yen          102.54 yen       148.26 yen  
  EPS Diluted      133.19 yen          102.53 yen                   
  Ann Div                               45.00 yen        45.00 yen  
  -Q2 Div           22.50 yen           22.50 yen                   
  -Q4 Div                               22.50 yen        22.50 yen  
 
  NOTE - Ono Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T